InsidersTradesSigma
Discover the complete record of transactions filed by Schafer Klaus, Director. Director active across 1 companies, notably Altimmune, Inc.. Aggregated, 1 disclosures have been logged. The latest transaction was filed on 20 June 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Klaus Schafer is a Board Member at Altimmune, Inc. He is involved in overseeing the company's operations and implementing its strategy. His expertise in the biopharmaceutical sector is a valuable asset for the organization.